Clinicians can combine technology with the perceptions of healthcare providers to help identify patients who skip medication doses, a study published in Pediatric Nephrology found. The study, ...
As the first and only FDA-approved oral GLP-1 launches, NovoCare® expands its offerings to help patients find access to comprehensive, clinician-led metabolic care nationwide. BOSTON--(BUSINESS WIRE)- ...
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...
Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic and Wegovy, is now the first company to manufacture and receive FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results